cancel CANCER

Welcome to the CANCELcancer Initiative, a transformative research program launched by the John Gnabre Science Research Institute. Our aim is to revolutionize cancer treatment by harnessing the power of nature and collaboration with leading experts in the field. We are dedicated to advancing the understanding of cancer and developing innovative therapies that can transform the lives of patients.


Cancer is a formidable adversary, affecting millions of lives worldwide. It is time to challenge the status quo and embrace a new approach in our fight against this devastating disease. At JGSRI, we believe in the power of the cancel culture concept, not towards individuals, but towards cancer itself. We are determined to cancel cancer by disrupting its growth and spreading through innovative natural remedies and therapies.


Leading our research efforts is our Senior Scientific Advisor, the remarkable Prof. Ru Chih Huang, a distinguished researcher from Johns Hopkins University. With almost six decades of experience, Prof. Huang has dedicated her life to unraveling the complexities of cancer. She firmly believes that plant-based molecules, used in combination, can successfully treat human cancers without harming normal cells.

The CANCELcancer Initiative focuses on the simultaneous use of almost two dozen natural cancer-fighting molecules, carefully studied by Prof. Huang’s laboratory for nearly 30 years. Each of these molecules fights cancer in a unique way, offering a comprehensive approach to treatment. 

Our aim is to extend a lifeline to recently diagnosed patients through Window of Opportunity Trials. Simultaneously, we aspire to provide relief and hope to existing patients by pursuing FDA Botanical Drug designation. This designation holds the potential to empower healthcare professionals to prescribe this natural product, unlocking new possibilities in cancer treatment.  



Phase 0 – Window of Opportunity Trials (WOT)

Our journey begins with raising funds for the Window of Opportunity Trials (WOT), initially focusing on three cancer types: Gynecologic, Pediatric, and Prostate. WOTs are clinical research studies conducted before standard treatment begins to assess potential new therapies or interventions. $6 million/$2 million per cancer typeDonate today!

Upon realizing the WOT fundraising goal for Gynecologic, Pediatric, and Prostate cancer, the WOT fundraiser will restart, targeting other cancer types

Phase I Clinical Trials

The CANCELcancer fundraiser will simultaneously collect donations for the Phase I Clinical Trials, initially for Gynecologic, Pediatric, and Prostate cancer. Phase I Clinical Trials aims to determine the highest dose humans, who have no underlying health conditions, can take without serious side effects. $16.8 million/$5.6 million per cancer typeDonate today!

Expansion to Phase II Clinical Trials

The CANCELcancer intitative will proceed to Phase II clinical trials after obtaining positive results from Phase I for each cancer type independently. To achieve FDA Botanical Drug designation, each cancer type must successfully complete Phase I-IV clinical trials. The CANCELcancer campaign includes Window of Opportunity Trials and Phases I and II Clinical Trials.  Phases III and IV will be funded through pharmacutical partnerships. Once all the phases of clinical trials are completed or until the treatment is no longer effective for a particular cancer type, a new fundraising pot will open for another cancer type. This process will continue, bringing us one step closer to eradicating cancer for good.

Each disease type must go through Phase I-IV clinical trials successfully for FDA Botanical Drug designation.


Become a CANCELcancer Ambassador

Join us in this transformative journey by becoming a CANCELcancer Ambassador. Your support and advocacy can make an extraordinary impact in our mission to Cancel Cancer. Spread the message, raise funds, and bring hope to those battling this relentless foe. Learn More

Support CANCELcancer

Your support isn’t just vital; it’s a lifeline for countless individuals facing cancer. Every contribution, whether big or small, brings us closer to our dream of canceling cancer from our lives.

Today, you can be a part of the movement to #CANCELcancer.

Donate to the Window of Opportunity Trials, the Phase I Clinical Trials, or specifically to the Gynecological, Pediatric, or Prostate cancer fund.

Thank you for your incredible support and unwavering dedication to our cause. Together, we can turn the tide and make cancer history.


September is Gynecological, Pediatric and Prostate Cancer Awareness Month, making it an opportune time to take action. Let’s unite in the fight against cancer and create a future where effective, natural treatments are available to all.

Your support matters. It holds the power to transform the landscape of cancer research and treatment, and to bring about a cancer-free future for generations to come.

With gratitude and determination,

John Gnabre Science Research Institute